99 related articles for article (PubMed ID: 16281935)
61. Gene expression patterns in acute myeloid leukemia correlate with centrosome aberrations and numerical chromosome changes.
Neben K; Tews B; Wrobel G; Hahn M; Kokocinski F; Giesecke C; Krause U; Ho AD; Krämer A; Lichter P
Oncogene; 2004 Mar; 23(13):2379-84. PubMed ID: 14767474
[TBL] [Abstract][Full Text] [Related]
62. Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells.
Fenski R; Flesch K; Serve S; Mizuki M; Oelmann E; Kratz-Albers K; Kienast J; Leo R; Schwartz S; Berdel WE; Serve H
Br J Haematol; 2000 Feb; 108(2):322-30. PubMed ID: 10691863
[TBL] [Abstract][Full Text] [Related]
63. Population-based age-specific incidences of cytogenetic subgroups of acute myeloid leukemia.
Bacher U; Kern W; Schnittger S; Hiddemann W; Haferlach T; Schoch C
Haematologica; 2005 Nov; 90(11):1502-10. PubMed ID: 16266897
[TBL] [Abstract][Full Text] [Related]
64. Mutations in ras proto-oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia.
Schaich M; Ritter M; Illmer T; Lisske P; Thiede C; Schäkel U; Mohr B; Ehninger G; Neubauer A
Br J Haematol; 2001 Feb; 112(2):300-7. PubMed ID: 11167822
[TBL] [Abstract][Full Text] [Related]
65. Towards a pathogenesis-oriented therapy of acute myeloid leukemia.
Hiddemann W; Spiekermann K; Buske C; Feuring-Buske M; Braess J; Haferlach T; Schoch C; Kern W; Schnittger S; Berdel W; Wörmann B; Heinecke A; Sauerland C; Büchner T;
Crit Rev Oncol Hematol; 2005 Nov; 56(2):235-45. PubMed ID: 16207531
[TBL] [Abstract][Full Text] [Related]
66. Aberrant gene promoter methylation in acute promyelocytic leukaemia: profile and prognostic significance.
Chim CS; Wong SY; Kwong YL
Br J Haematol; 2003 Aug; 122(4):571-8. PubMed ID: 12899712
[TBL] [Abstract][Full Text] [Related]
67. Quantitative multiplex quantum dot in-situ hybridisation based gene expression profiling in tissue microarrays identifies prognostic genes in acute myeloid leukaemia.
Tholouli E; MacDermott S; Hoyland J; Yin JL; Byers R
Biochem Biophys Res Commun; 2012 Aug; 425(2):333-9. PubMed ID: 22842570
[TBL] [Abstract][Full Text] [Related]
68. Methylation profiling in acute myeloid leukemia.
Toyota M; Kopecky KJ; Toyota MO; Jair KW; Willman CL; Issa JP
Blood; 2001 May; 97(9):2823-9. PubMed ID: 11313277
[TBL] [Abstract][Full Text] [Related]
69. CD200 as a prognostic factor in acute myeloid leukaemia.
Tonks A; Hills R; White P; Rosie B; Mills KI; Burnett AK; Darley RL
Leukemia; 2007 Mar; 21(3):566-8. PubMed ID: 17252007
[No Abstract] [Full Text] [Related]
70. Biological models for leukaemia and lymphoma.
Greaves MF
IARC Sci Publ; 2004; (157):351-72. PubMed ID: 15055306
[TBL] [Abstract][Full Text] [Related]
71. Presence of high-ERG expression is an independent unfavorable prognostic marker in MLL-rearranged childhood myeloid leukemia.
Pigazzi M; Masetti R; Martinolli F; Manara E; Beghin A; Rondelli R; Locatelli F; Fagioli F; Pession A; Basso G
Blood; 2012 Jan; 119(4):1086-7; author reply 1087-8. PubMed ID: 22282493
[No Abstract] [Full Text] [Related]
72. A novel type of
Duployez N; Chebrek L; Helevaut N; Fournier E; Bemba M; Caillault A; Geffroy S; Preudhomme C
Haematologica; 2018 Dec; 103(12):e575-e577. PubMed ID: 29903763
[No Abstract] [Full Text] [Related]
73. On counting tandem duplication trees.
Yang J; Zhang L
Mol Biol Evol; 2004 Jun; 21(6):1160-3. PubMed ID: 15014148
[No Abstract] [Full Text] [Related]
74. c-FMS mutational analysis in acute myeloid leukaemia.
Abu-Duhier FM; Goodeve AC; Wilson GA; Peake IR; Reilly JT
Br J Haematol; 2003 Nov; 123(4):749-50. PubMed ID: 14616987
[No Abstract] [Full Text] [Related]
75. A molecular study of pediatric pilomyxoid and pilocytic astrocytomas: Genome-wide copy number screening, retrospective analysis of clinicopathological features and long-term clinical outcome.
AlShail E; Alahmari AN; Dababo AAM; Alsagob M; Al-Hindi H; Khalil H; Al Masseri Z; AlSalamah R; Almohseny E; Alduhaish A; Colak D; Kaya N
Front Oncol; 2023; 13():1034292. PubMed ID: 36860324
[TBL] [Abstract][Full Text] [Related]
76. Dihydroartemisinin-induced apoptosis in human acute monocytic leukemia cells.
Cao JT; Mo HM; Wang Y; Zhao K; Zhang TT; Wang CQ; Xu KL; Han ZH
Oncol Lett; 2018 Mar; 15(3):3178-3184. PubMed ID: 29435054
[TBL] [Abstract][Full Text] [Related]
77. Prior hypomethylating agent use lacks impact on clinical outcome in patients with secondary acute myeloid leukemia arising from myelodysplastic syndromes treated with standard induction chemotherapy.
Subari S; Baidoun F; Hreh M; Patnaik M; Hashmi S; Elliott M; Hogan W; Litzow M; Al-Kali A
Int J Hematol; 2016 Apr; 103(4):409-15. PubMed ID: 26781617
[TBL] [Abstract][Full Text] [Related]
78. The evolving landscape in the therapy of acute myeloid leukemia.
Peloquin GL; Chen YB; Fathi AT
Protein Cell; 2013 Oct; 4(10):735-46. PubMed ID: 23982740
[TBL] [Abstract][Full Text] [Related]
79. Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profiling.
Olesen LH; Aggerholm A; Andersen BL; Nyvold CG; Guldberg P; Nørgaard JM; Hokland P
Br J Haematol; 2005 Nov; 131(4):457-67. PubMed ID: 16281935
[TBL] [Abstract][Full Text] [Related]
80. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
